826
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor: Clinical Oncology

Hypoxia and local tumour control in squamous cell carcinoma of the anus – a hypothesis-generating study

ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 1132-1135 | Received 20 Apr 2022, Accepted 07 Jun 2022, Published online: 22 Jun 2022

Figures & data

Figure 1. Results on hypoxia classification of squamous cell carcinoma of the anus (SCCA) tissues using a 15-gene hypoxia classifier. A: Comparison between the mean expression level of each of the 15 genes between the SCCA samples on the x-axis and a representative head and neck squamous cell carcinoma (HNSCC) cohort on the y-axis. B: The sum scores for the 15 genes. A negative score categorises the tumour as less hypoxic, and a positive score categorises the tumour as more hypoxic. Each bar represents a case. For patients with local recurrence, the number of months from the end of treatment to the time for diagnosis of recurrence and tumour characteristics are measured in the table. C: Aalen-Johansen estimated correlation between hypoxia classification and local tumour control.

Figure 1. Results on hypoxia classification of squamous cell carcinoma of the anus (SCCA) tissues using a 15-gene hypoxia classifier. A: Comparison between the mean expression level of each of the 15 genes between the SCCA samples on the x-axis and a representative head and neck squamous cell carcinoma (HNSCC) cohort on the y-axis. B: The sum scores for the 15 genes. A negative score categorises the tumour as less hypoxic, and a positive score categorises the tumour as more hypoxic. Each bar represents a case. For patients with local recurrence, the number of months from the end of treatment to the time for diagnosis of recurrence and tumour characteristics are measured in the table. C: Aalen-Johansen estimated correlation between hypoxia classification and local tumour control.

Table 1. Pretreatment Characteristics.

Data availability statement

Data not available due to legal restrictions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.